Literature DB >> 3472524

Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form.

N R Campbell, J A Van Loon, R M Weinshilboum.   

Abstract

Phenol sulfotransferase (PST) catalyzes the sulfate conjugation of phenolic and catechol drugs and neurotransmitters. Human platelets and brain contain at least two forms of PST. One form is relatively thermolabile (TL) and catalyzes the sulfate conjugation of monoamines such as dopamine. The other is thermostable (TS) and catalyzes the sulfation of "simple" phenols such as phenol and p-nitrophenol. We found that homogenates of human liver also contain two forms of PST that are similar to brain and platelet TL and TS PST with regard to substrate specificities, thermal stabilities and sensitivities to inhibitors. Optimal conditions were determined for the assay of these two activities in human liver homogenates. The apparent Km of liver homogenate TL PST for dopamine was 27 microM. The apparent Km of the TS form of the enzyme for p-nitrophenol was 0.94 microM. Human liver TS PST also catalyzed the sulfate conjugation of dopamine, but with an apparent Km of 5 mM, over two orders of magnitude higher than that of TL PST. Two different peaks of TS PST activity were separated from the TL activity by ion exchange chromatography of human liver preparations. Both peaks of TS PST activity were partially purified and characterized. Both had similar substrate specificities and inhibitor sensitivities. Km values of TS PST peak I for p-nitrophenol and for 3'-phosphoadenosine-5'-phosphosulfate were 0.91 and 0.86 microM, respectively, while the Km values of TS PST peak II for these two cosubstrates for the reaction were 0.43 and 0.64 microM, respectively. However, the TS PST activity in peak II was significantly more thermolabile than was the activity in peak I. These results are compatible with the conclusion that human liver homogenates contain at least two forms of PST, forms with properties similar to those of TS and TL PST in homogenates of human cerebral cortex and platelets. In addition, human liver contains two isozymes of TS PST.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3472524     DOI: 10.1016/0006-2952(87)90108-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  23 in total

Review 1.  Sulfotransferase gene copy number variation: pharmacogenetics and function.

Authors:  S J Hebbring; A M Moyer; R M Weinshilboum
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

2.  Renal impairment associated with an acute paracetamol overdose in the absence of hepatotoxicity.

Authors:  N R Campbell; B Baylis
Journal:  Postgrad Med J       Date:  1992-02       Impact factor: 2.401

3.  Reduced platelet phenolsulphotransferase activity towards dopamine and 5-hydroxytryptamine in migraine.

Authors:  A L Jones; R C Roberts; D W Colvin; G L Rubin; M W Coughtrie
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

4.  Stereoselective metabolism of RS-albuterol in humans.

Authors:  T Walle; E A Eaton; U K Walle; G R Pesola
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

5.  Minoxidil sulphation in human liver and platelets. A study of interindividual variability.

Authors:  G M Pacifici; R Bigotti; G Marchi; L Giuliani
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Sulphation and glucuronidation of ritodrine in human foetal and adult tissues.

Authors:  G M Pacifici; M Kubrich; L Giuliani; M de Vries; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity.

Authors:  U K Walle; G R Pesola; T Walle
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

8.  Ritodrine sulphation in the human liver and duodenal mucosa: interindividual variability.

Authors:  G M Pacifici; M C Quilici; B Giulianetti; R Spisni; M Nervi; L Giuliani; R Gomeni
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jan-Mar       Impact factor: 2.441

Review 9.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  Functional characterization of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies.

Authors:  M E Veronese; W Burgess; X Zhu; M E McManus
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.